Latest filing published 17 Sept 2024 for IGM Biosciences, Inc., €41k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Fred Schwarzer in IGM Biosciences, Inc., where the filings describe the role as chief executive. The record holds 18 filings, for trades running from 14 May 2021 to 13 September 2024.
Every open-market trade on record is a sale: 7 sales worth €364k. Besides market trades, the filings include 11 share grants. In 2024 alone, the filings show no purchases and 2 sales.
The newest entry dates from 17 September 2024: an open-market sale of €41k, in IGM Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations